The latest research suggests that glutathione deficiency is the most likely cause of serious manifestations and death in patients with Covid-19
Between 1990 and 2019, there was a 54% increase in heart disease related deaths, according to the World Health Organization (Source: Our World in Data)
This article explores how GLP-1 agonists work, their availability in the UK, safety considerations, and NHS guidance for appropriate use
With the increase in drug categories, some studies have focused on improving the safety, absorption efficiency and action time of drugs to strive for perfection
A dose of 0.2 mg/kg seems safe and effective for most people, but individual tolerance should always be considered
Not ready for a membership